Eppen Comments on Future of Recreational Marijuana Law in Massachusetts
04 October 2017
Law360
Partner Ron Eppen is quoted in a Law360 article, “A Guide to Marijuana Legalization in Massachusetts,” about the implementation of a new law legalizing the recreational use of marijuana.
If Massachusetts follows in the path of Colorado and other states that have already legalized marijuana, Eppen said, the small not-profit dispensaries now operated by people who are in it for the culture will likely be replaced by big for-profit corporations that are in it for the money.
“What you’ve seen as the type of dollars that are involved have gotten larger and larger, is a professionalization of cannabis companies, in terms of their management,” he said. “Along with this has come basically a rush of investors who are looking to get in on the action, because the types of returns you can get from investment in a cannabis company are significantly more beneficial to investors than a typical early stage venture capital.”
If Massachusetts follows in the path of Colorado and other states that have already legalized marijuana, Eppen said, the small not-profit dispensaries now operated by people who are in it for the culture will likely be replaced by big for-profit corporations that are in it for the money.
“What you’ve seen as the type of dollars that are involved have gotten larger and larger, is a professionalization of cannabis companies, in terms of their management,” he said. “Along with this has come basically a rush of investors who are looking to get in on the action, because the types of returns you can get from investment in a cannabis company are significantly more beneficial to investors than a typical early stage venture capital.”
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"